Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Victoza® (liraglutide) – First-time authorized brand alternative

June 24, 2024 - Teva launched an authorized brand alternative of Novo Nordisk’s Victoza (liraglutide) injection.

Download PDF

Rx navigation